tiprankstipranks
Advertisement
Advertisement
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
PremiumCompany AnnouncementsNiagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
10d ago
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
Premium
The Fly
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
10d ago
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
Premium
Ratings
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
10d ago
NAGE Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsNAGE Upcoming Earnings Report: What to Expect?
13d ago
Niagen Bioscience announces publication on muscle epigenetic age
Premium
The Fly
Niagen Bioscience announces publication on muscle epigenetic age
18d ago
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
Premium
The Fly
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
25d ago
Niagen Bioscience initiated with a Buy at Freedom Broker
PremiumThe FlyNiagen Bioscience initiated with a Buy at Freedom Broker
1M ago
Niagen Bioscience Shareholders Back Board and Governance Measures
Premium
Company Announcements
Niagen Bioscience Shareholders Back Board and Governance Measures
2M ago
Niagen Bioscience files $125M mixed securities shelf
Premium
The Fly
Niagen Bioscience files $125M mixed securities shelf
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100